News Releases - ProSciento

December 10, 2021 |

News Releases

ProSciento Appoints Michelle Thompson, PhD, MBA, as Executive Vice President of Global Business Development

July 8, 2021 |

News Releases

ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science

September 10, 2020 |

News Releases

ProSciento Closes Growth Financing from 1315 Capital

September 1, 2020 |

News Releases

ProSciento Appoints Stephen Mullennix as Chief Financial Officer

June 15, 2020 |

News Releases

ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California

February 6, 2020 |

News Releases

ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH)

November 12, 2019 |

News Releases

ProSciento to Present at the Diabetes Technology Annual Meeting

August 13, 2019 |

News Releases

ProSciento Expands Senior Management Team, Appoints Siva Mullapudi as Senior Director of CRO Services

August 5, 2019 |

News Releases

ProSciento to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting

June 17, 2019 |

News Releases

ProSciento Expands Executive Team, Appoints Helge Guenther as Chief Information Officer

May 29, 2019 |

News Releases

ProSciento to Present at the American Diabetes Association 79th Scientific Sessions

April 15, 2019 |

News Releases

ProSciento’s Chief Medical Officer Dr. Linda Morrow to Present at 3rd Annual NASH Summit

April 10, 2019 |

News Releases

Second Edition Textbook, ‘Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease,’ Provides Roadmap for Preclinical and Clinical Research

March 19, 2019 |

News Releases

ProSciento Hosts Second NASH Roundtable of Leading Experts During the International Liver Congress in Vienna

January 2, 2019 |

News Releases

ProSciento Announces Poster Presentation at the 2019 NASH-TAG Conference

December 5, 2018 |

News Releases

ProSciento Forms NASH Roundtable, a Forum of Leading Academic and Clinical Development Experts, to Advise Biopharma Drug Development Programs

October 26, 2018 |

News Releases

ProSciento Hosts Inaugural NASH Roundtable of Leading Experts at AASLD Annual Meeting

September 27, 2018 |

News Releases

ProSciento to Present at the 54th European Association for the Study of Diabetes (EASD) Annual Meeting

August 6, 2018 |

News Releases

ProSciento Expands Executive Team, Appoints Brian Mooney Chief Operating Officer

June 21, 2018 |

News Releases

ProSciento and Tidepool Collaborate to Integrate Diabetes Device Data Aggregation Platform into Clinical Trials

June 19, 2018 |

News Releases

ProSciento Appoints Dr. Carine Beysen, Industry Expert in Stable Isotope Research, to Senior Scientific Team

June 13, 2018 |

News Releases

ProSciento to Present at the American Diabetes Association 78th Scientific Sessions

April 19, 2018 |

News Releases

ProSciento Presents Scientific Data at the 2nd Annual Nash Summit

March 7, 2018 |

News Releases

ProSciento Expands Asia Pacific Operations with Office in Australia

November 6, 2017 |

News Releases

ProSciento CEO to Present at the European Association for the Study of the Liver (EASL) NAFLD Summit

September 9, 2017 |

News Releases

ProSciento Presents at the 53rd European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon

June 7, 2017 |

News Releases

ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment

June 6, 2017 |

News Releases

ProSciento Presents at the American Diabetes Association’s 77th Annual Scientific Sessions in San Diego

May 30, 2017 |

News Releases

ProSciento Appoints Dr. Kelvin Logan, Former Executive at INC Research and Quintiles, to its Board of Directors

May 1, 2017 |

News Releases

ProSciento and Antaros Medical Present Scientific Data at the 2nd International NASH Biomarkers Workshop

February 15, 2017 |

News Releases

mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population

September 14, 2016 |

News Releases

ProSciento and Antaros Medical Form Strategic Alliance to Incorporate Advanced Functional Imaging Techniques into NASH Clinical Research

July 28, 2016 |

News Releases

ProSciento and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH

June 10, 2016 |

News Releases

ProSciento and LMC Diabetes Launch Strategic Partnership to Conduct Cross-Border Multi-Site Trials in Diabetes and Metabolism

June 9, 2016 |

News Releases

ProSciento and mySugr Collaborate to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions

June 6, 2016 |

News Releases

ProSciento Presents at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans

April 5, 2016 |

News Releases

ProSciento Assembles Team of 92 and Raises More Than $27,000 for American Diabetes Association’s Tour de Cure in San Diego

November 24, 2015 |

News Releases

ProSciento Appoints Meryl Wiernik as Senior Director of CRO Services

November 9, 2015 |

News Releases

Congratulations to Hanmi Pharmaceutical Co., Ltd.

October 29, 2015 |

News Releases

ProSciento’s Corporate Team is Proud to Celebrate Its 11th Year Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego

October 28, 2015 |

News Releases

ProSciento and KineMed Collaborate to Pursue Circulating Biomarkers for NAFLD/NASH Clinical Research

October 28, 2015 |

News Releases

ProSciento Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH

October 13, 2015 |

News Releases

ProSciento Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year

October 8, 2015 |

News Releases

ProSciento Publishes White Paper Series Focused on the Current State of Diabetes, Obesity and NAFLD/NASH Clinical Research and Development

September 10, 2015 |

News Releases

ProSciento Presents Diabetes, Obesity and NASH Research Study Results at the European Association for the Study of Diabetes Annual Meeting

June 4, 2015 |

News Releases

ProSciento and Gubra Join Forces in Metabolism Focused ‘Discover & Translate’ Partnership

May 29, 2015 |

News Releases

ProSciento Presents at the American Diabetes Association’s 75th Annual Scientific Sessions in Boston

May 7, 2015 |

News Releases

ProSciento Expands Clinical Development Leadership Team With Prominent Industry Experts Drs. Michael Trautmann and Gordon Brandt

April 15, 2015 |

News Releases

ProSciento Assembles Team of 70 and Raises $35,000 for American Diabetes Association’s Tour de Cure in San Diego

January 22, 2015 |

News Releases

New Textbook “Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development” Provides Critical Review of Current and Emerging Clinical Investigation Methods

Get in Touch

Key Takeaways from the 4th Annual NASH Roundtable™ Virtual Forum

ProSciento Becomes a California-Wide Sponsor of JDRF’s One Walks

ProSciento Appoints Lynn Rudolph as Vice President of Human Resources

ProSciento Co-Hosts the 4th Annual NASH Roundtable Virtual Forum

ProSciento Appoints Michelle Thompson, PhD, MBA, as Executive Vice President of Global Business Development

ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science

ProSciento Closes Growth Financing from 1315 Capital

ProSciento Appoints Stephen Mullennix as Chief Financial Officer

ProSciento, Clinical Research Organization (CRO) Focused on Metabolic Diseases, Institutes Rapid COVID-19 Antigen and Antibody Testing at Clinical Research Unit in Southern California

ProSciento and Nordic Bioscience Form Strategic Partnership to Develop Translational Biomarkers for Nonalcoholic Steatohepatitis (NASH)

ProSciento to Present at the Diabetes Technology Annual Meeting

ProSciento Expands Senior Management Team, Appoints Siva Mullapudi as Senior Director of CRO Services

ProSciento to Present at the European Association for the Study of Diabetes (EASD) Annual Meeting

ProSciento Expands Executive Team, Appoints Helge Guenther as Chief Information Officer

ProSciento to Present at the American Diabetes Association 79th Scientific Sessions

ProSciento’s Chief Medical Officer Dr. Linda Morrow to Present at 3rd Annual NASH Summit

Second Edition Textbook, ‘Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease,’ Provides Roadmap for Preclinical and Clinical Research

ProSciento Hosts Second NASH Roundtable of Leading Experts During the International Liver Congress in Vienna

ProSciento Announces Poster Presentation at the 2019 NASH-TAG Conference

ProSciento Forms NASH Roundtable, a Forum of Leading Academic and Clinical Development Experts, to Advise Biopharma Drug Development Programs

ProSciento Hosts Inaugural NASH Roundtable of Leading Experts at AASLD Annual Meeting

ProSciento to Present at the 54th European Association for the Study of Diabetes (EASD) Annual Meeting

ProSciento Expands Executive Team, Appoints Brian Mooney Chief Operating Officer

ProSciento and Tidepool Collaborate to Integrate Diabetes Device Data Aggregation Platform into Clinical Trials

ProSciento Appoints Dr. Carine Beysen, Industry Expert in Stable Isotope Research, to Senior Scientific Team

ProSciento to Present at the American Diabetes Association 78th Scientific Sessions

ProSciento Presents Scientific Data at the 2nd Annual Nash Summit

ProSciento Expands Asia Pacific Operations with Office in Australia

ProSciento CEO to Present at the European Association for the Study of the Liver (EASL) NAFLD Summit

ProSciento Presents at the 53rd European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon

ProSciento and OWL Metabolomics Form Strategic Collaboration Focused on Accelerating NAFLD/NASH Clinical Trial Recruitment

ProSciento Presents at the American Diabetes Association’s 77th Annual Scientific Sessions in San Diego

ProSciento Appoints Dr. Kelvin Logan, Former Executive at INC Research and Quintiles, to its Board of Directors

ProSciento and Antaros Medical Present Scientific Data at the 2nd International NASH Biomarkers Workshop

mySugr Demonstrates Clinically Significant Impact on Diabetes Management for High Risk Population

ProSciento and Antaros Medical Form Strategic Alliance to Incorporate Advanced Functional Imaging Techniques into NASH Clinical Research

ProSciento and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH

ProSciento and LMC Diabetes Launch Strategic Partnership to Conduct Cross-Border Multi-Site Trials in Diabetes and Metabolism

ProSciento and mySugr Collaborate to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions

ProSciento Presents at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans

ProSciento Assembles Team of 92 and Raises More Than $27,000 for American Diabetes Association’s Tour de Cure in San Diego

ProSciento Appoints Meryl Wiernik as Senior Director of CRO Services

Congratulations to Hanmi Pharmaceutical Co., Ltd.

ProSciento’s Corporate Team is Proud to Celebrate Its 11th Year Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego

ProSciento and KineMed Collaborate to Pursue Circulating Biomarkers for NAFLD/NASH Clinical Research

ProSciento Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH

ProSciento Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year

ProSciento Publishes White Paper Series Focused on the Current State of Diabetes, Obesity and NAFLD/NASH Clinical Research and Development

ProSciento Presents Diabetes, Obesity and NASH Research Study Results at the European Association for the Study of Diabetes Annual Meeting

ProSciento and Gubra Join Forces in Metabolism Focused ‘Discover & Translate’ Partnership

ProSciento Presents at the American Diabetes Association’s 75th Annual Scientific Sessions in Boston

ProSciento Expands Clinical Development Leadership Team With Prominent Industry Experts Drs. Michael Trautmann and Gordon Brandt

ProSciento Assembles Team of 70 and Raises $35,000 for American Diabetes Association’s Tour de Cure in San Diego

New Textbook “Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development” Provides Critical Review of Current and Emerging Clinical Investigation Methods